Skip to main content

Articles

Page 61 of 71

  1. Non-sinonasal neuroendocrine carcinomas (NSNECs) of the head and neck are considered an unfrequent clinico-pathological entity. Combined modality treatment represents an established therapeutic option for undi...

    Authors: Pierfrancesco Franco, Gianmauro Numico, Fernanda Migliaccio, Paola Catuzzo, Domenico Cante, Paola Ceroni, Piera Sciacero, Pierpaolo Carassai, Paolo Canzi, Maria Rosa La Porta, Giuseppe Girelli, Valeria Casanova Borca, Massimo Pasquino, Santi Tofani, Franca Ozzello and Umberto Ricardi
    Citation: Radiation Oncology 2012 7:21
  2. The purpose of this study was to compare dose distributions from three different algorithms with the x-ray Voxel Monte Carlo (XVMC) calculations, in actual computed tomography (CT) scans for use in stereotacti...

    Authors: Wataru Takahashi, Hideomi Yamashita, Naoya Saotome, Yoshio Iwai, Akira Sakumi, Akihiro Haga and Keiichi Nakagawa
    Citation: Radiation Oncology 2012 7:20
  3. For radiotherapy of the head and neck, 5-point mask immobilization is used to stabilize the shoulders. Still, the daily position of the shoulders during treatment may be different from the position in the trea...

    Authors: Emily Neubauer, Lei Dong, David S Followill, Adam S Garden, Laurence E Court, R Allen White and Stephen F Kry
    Citation: Radiation Oncology 2012 7:19
  4. The timely and appropriate adoption of new radiation therapy (RT) technologies is a challenge both in terms of providing of optimal patient care and managing health care resources. Relatively little is known r...

    Authors: Eman Z AlDuhaiby, Stephen Breen, Jean-Pierre Bissonnette, Michael Sharpe, Linda Mayhew, Scott Tyldesley, Derek R Wilke and David C Hodgson
    Citation: Radiation Oncology 2012 7:18
  5. There are limited data on accelerated partial breast irradiation (APBI) using external beam techniques. Moreover, there are recent reports of increased fibrosis and unacceptable cosmesis with APBI using extern...

    Authors: Arif Y Shaikh, Michael A LaCombe, Hongyan Du, Vathsala T Raghavan, Ranjeev K Nanda and William D Bloomer
    Citation: Radiation Oncology 2012 7:17
  6. To report the initial institute experience in terms of dosimetric and technical aspects in stereotactic body radiation therapy (SBRT) delivered using flattening filter free (FFF) beam in patients with liver le...

    Authors: Pietro Mancosu, Simona Castiglioni, Giacomo Reggiori, Maddalena Catalano, Filippo Alongi, Chiara Pellegrini, Stefano Arcangeli, Angelo Tozzi, Francesca Lobefalo, Antonella Fogliata, Piera Navarria, Luca Cozzi and Marta Scorsetti
    Citation: Radiation Oncology 2012 7:16
  7. Rectal toxicity is less common after 125I seed implant brachytherapy for prostate cancer, and intraoperative rectal dose-volume constraints (the constraint) is still undetermined in pioneering studies. As our con...

    Authors: Ryuji Nakamura, Koyo Kikuchi, Susumu Tanji, Tomonori Yabuuchi, Ikuko Uwano, Satoshi Yamaguchi, Hisanori Ariga and Tomoaki Fujioka
    Citation: Radiation Oncology 2012 7:15
  8. In comparison to the conventional whole-prostate dose escalation, an integrated boost to the macroscopic malignant lesion might potentially improve tumor control rates without increasing toxicity. Quality of l...

    Authors: Michael Pinkawa, Marc D Piroth, Richard Holy, Jens Klotz, Victoria Djukic, Nuria Escobar Corral, Mariana Caffaro, Oliver H Winz, Thomas Krohn, Felix M Mottaghy and Michael J Eble
    Citation: Radiation Oncology 2012 7:14
  9. To identify pretreatment carcinoembryonic antigen (CEA) levels as a risk factor for para-aortic lymph node (PALN) recurrence following concurrent chemoradiotherapy (CCRT) for cervical cancer.

    Authors: Eng-Yen Huang, Yu-Jie Huang, Chan-Chao Chanchien, Hao Lin, Chong-Jong Wang, Li-Min Sun, Chin-Wen Tseng, Ching-Chou Tsai, Yu-Che Ou, Hung-Chun Fu, Hui-Chun Chen, Hsuan-Chih Hsu and Chang-Yu Wang
    Citation: Radiation Oncology 2012 7:13
  10. This is an observational study and the aim is to evaluate the effect of dietary supplements based on Resveratrol, Lycopene, Vitamin C and Anthocyanins (Ixor®) in reducing skin toxicity due to external beam radiot...

    Authors: Rossella Di Franco, MariaGrazia Calvanese, Paola Murino, Roberto Manzo, Cesare Guida, Davide Di Gennaro, Caterina Anania and Vincenzo Ravo
    Citation: Radiation Oncology 2012 7:12
  11. To evaluate the accuracy of the combined maximum and minimum intensity projection-based internal target volume (ITV) delineation in 4-dimensional (4D) CT scans for liver malignancies.

    Authors: Jin Liu, Jia-Zhou Wang, Jian-Dong Zhao, Zhi-Yong Xu and Guo-Liang Jiang
    Citation: Radiation Oncology 2012 7:11
  12. Although proton radiotherapy is a promising new approach for cancer patients, functional interference is a concern for patients with implantable cardioverter defibrillators (ICDs). The purpose of this study wa...

    Authors: Takayuki Hashimoto, Tomonori Isobe, Haruko Hashii, Hiroaki Kumada, Hiroshi Tada, Toshiyuki Okumura, Koji Tsuboi, Takeji Sakae, Kazutaka Aonuma and Hideyuki Sakurai
    Citation: Radiation Oncology 2012 7:10
  13. 131I-MIBG therapy for neuroendocrine tumours may be dose limited. The common range of applied cumulative activities is 10-40 GBq. We report the uneventful cumulative administration of 111 GBq (= 3 Ci) 131I-MIBG i...

    Authors: Samer Ezziddin, Amir Sabet, Yon-Dschun Ko, Sunny Xun, Alexander Matthies and Hans-Jürgen Biersack
    Citation: Radiation Oncology 2012 7:8
  14. Conventional step&shoot intensity modulated radio therapy (IMRT) approaches potentially lead to treatment plans with high numbers of segments and monitor units (MU) and, therefore, could be time consuming at t...

    Authors: Marcello Sabatino, Matthias Kretschmer, Klemens Zink and Florian Würschmidt
    Citation: Radiation Oncology 2012 7:7
  15. Ionizing radiation-induced hematopoietic injury could occur either due to accidental exposure or due to diagnostic and therapeutic interventions. Currently there is no approved drug to mitigate radiation toxic...

    Authors: Shubhankar Suman, Manoj Maniar, Albert J Fornace Jr and Kamal Datta
    Citation: Radiation Oncology 2012 7:6
  16. We hypothesized that quantitative PET parameters may have predictive value beyond that of traditional clinical factors such as the International Prognostic Score (IPS) among Hodgkin's disease (HD) patients.

    Authors: Diane Tseng, Leelanand P Rachakonda, Zheng Su, Ranjana Advani, Sandra Horning, Richard T Hoppe, Andrew Quon, Edward E Graves, Billy W Loo Jr and Phuoc T Tran
    Citation: Radiation Oncology 2012 7:5
  17. Radiation-induced skin injury remains a serious concern for radiation therapy. Heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme catabolism, has been reported to have potential antioxidant and anti-apo...

    Authors: Shuyu Zhang, Chuanjun Song, Jundong Zhou, Ling Xie, Xingjun Meng, Pengfei Liu, Jianping Cao, Xueguang Zhang, Wei-Qun Ding and Jinchang Wu
    Citation: Radiation Oncology 2012 7:4
  18. Treatment of non-small cell lung cancer (NSCLC) is challenging in many ways. One of the problems is disappointing local control rates in larger volume disease. Moreover, the likelihood of both nodal and distan...

    Authors: Carsten Nieder, Adam Pawinski, Astrid Dalhaug and Nicolaus Andratschke
    Citation: Radiation Oncology 2012 7:3
  19. To evaluate the clinical outcomes and patterns of failure in patients with nasopharyngeal carcinoma (NPC) treated with intensity modulated radiotherapy (IMRT) in Northwest China.

    Authors: Jianhua Wang, Mei Shi, Yuesheng Hsia, Shanquan Luo, Lina Zhao, Man Xu, Feng Xiao, Xuehai Fu, Jianping Li, Bin Zhou and Xiaoli Long
    Citation: Radiation Oncology 2012 7:2
  20. For studying proliferation and determination of survival of cancer cells after irradiation, the multiple MTT assay, based on the reduction of a yellow water soluble tetrazolium salt to a purple water insoluble...

    Authors: Karl Buch, Tanja Peters, Thomas Nawroth, Markus Sänger, Heinz Schmidberger and Peter Langguth
    Citation: Radiation Oncology 2012 7:1
  21. Extranodal natural killer/T-cell lymphoma (ENKTL), nasal type, is a rare form of non-Hodgkin lymphoma. Treatment of ENKTL primarily relies on radiation; thus, proper delineation of target volumes is critical. ...

    Authors: Shannon L MacDonald, Liam Mulroy, Derek R Wilke and Steven Burrell
    Citation: Radiation Oncology 2011 6:182
  22. This study examined the population-based use and outcomes of brain radiotherapy (BRT) for brain metastases (BM) from breast cancer with a focus on repeat BRT in the trastuzumab era.

    Authors: Irene Karam, Alan Nichol, Ryan Woods and Scott Tyldesley
    Citation: Radiation Oncology 2011 6:181
  23. This study seeks to increase clinical operational efficiency and accelerator beam consistency by retrospectively investigating the application of statistical process control (SPC) to linear accelerator beam st...

    Authors: Charles M Able, Carnell J Hampton, Alan H Baydush and Michael T Munley
    Citation: Radiation Oncology 2011 6:180
  24. To define the dosimetric coverage of level I/II axillary volumes and the lung volume irradiated in postmastectomy radiotherapy (PMRT) following tissue expander placement.

    Authors: James K Russo, Kent E Armeson, Ryan Rhome, Michele Spanos and Jennifer L Harper
    Citation: Radiation Oncology 2011 6:179
  25. To investigate combining unmodulated electron beams with intensity-modulated radiation therapy to improve dose distributions for superficial head and neck cancers, and to compare mixed beam plans with helical tom...

    Authors: Olivier Blasi, Jonas D Fontenot, Robert S Fields, John P Gibbons and Kenneth R Hogstrom
    Citation: Radiation Oncology 2011 6:178
  26. Targeted drugs have augmented the cancer treatment armamentarium. Based on the molecular specificity, it was initially believed that these drugs had significantly less side effects. However, currently it is ac...

    Authors: Maximilian Niyazi, Cornelius Maihoefer, Mechthild Krause, Claus Rödel, Wilfried Budach and Claus Belka
    Citation: Radiation Oncology 2011 6:177
  27. To explore the risk factors of distant brain failure (DBF) for patients with brain metastasis (BM) who were treated with stereotactic radiotherapy alone and to group the patients on the basis of their risk lev...

    Authors: Xiu-jun Chen, Jian-ping Xiao, Xiang-pan Li, Xue-song Jiang, Ye Zhang, Ying-jie Xu, Jian-rong Dai and Ye-xiong Li
    Citation: Radiation Oncology 2011 6:175
  28. Radiation induced secondary cancers are a rare but severe late effect after breast conserving therapy. Intraoperative radiotherapy (IORT) is increasingly used during breast conserving surgery. The purpose of t...

    Authors: Muhammad Hammad Aziz, Frank Schneider, Sven Clausen, Elena Blank, Carsten Herskind, Muhammad Afzal and Frederik Wenz
    Citation: Radiation Oncology 2011 6:174
  29. Conventional external beam radiotherapy is a standard procedure for treatment of spinal metastases. In case of progression spinal cord tolerance limits further radiotherapy in pre-irradiated areas. Spinal ster...

    Authors: Katharina Nikolajek, Markus Kufeld, Alexander Muacevic, Berndt Wowra, Maximilian Niyazi and Ute Ganswindt
    Citation: Radiation Oncology 2011 6:173
  30. Spinal radiosurgery is a quickly evolving technique in the radiotherapy and neurosurgical communities. However, the methods of spine radiosurgery have not been standardized. This article describes the results ...

    Authors: Matthias Guckenberger, Reinhart A Sweeney, John C Flickinger, Peter C Gerszten, Ronald Kersh, Jason Sheehan and Arjun Sahgal
    Citation: Radiation Oncology 2011 6:172
  31. It has been postulated that ionizing radiation induces breast cancers among atomic bomb (A-bomb) survivors. We have reported a higher incidence of HER2 and C-MYC oncogene amplification in breast cancers from A-bo...

    Authors: Masahiro Oikawa, Koh-ichiro Yoshiura, Hisayoshi Kondo, Shiro Miura, Takeshi Nagayasu and Masahiro Nakashima
    Citation: Radiation Oncology 2011 6:168
  32. Radiotherapy (RT) remains an effective treatment in patients with acromegaly refractory to medical and/or surgical interventions, with durable tumor control and biochemical remission; however, there are still ...

    Authors: Giuseppe Minniti, Claudia Scaringi and Riccardo Maurizi Enrici
    Citation: Radiation Oncology 2011 6:167
  33. Brain metastases occur in 30-50% of Non-small cell lung cancer (NSCLC) patients and confer a worse prognosis and quality of life. These patients are usually treated with Whole-brain radiotherapy (WBRT) followe...

    Authors: Oscar Arrieta, Cynthia Villarreal-Garza, Jesús Zamora, Mónika Blake-Cerda, María D de la Mata, Diego G Zavala, Saé Muñiz-Hernández and Jaime de la Garza
    Citation: Radiation Oncology 2011 6:166
  34. [18F]FAZA is a PET biomarker with great potential for imaging tumor hypoxia. Aim of our study was to compare [18F]FAZA uptake in mice with subcutaneous exogenous CT26 colon carcinomas and endogenous polyoma middl...

    Authors: Florian C Maier, Manfred Kneilling, Gerald Reischl, Funda Cay, Daniel Bukala, Andreas Schmid, Martin S Judenhofer, Martin Röcken, Hans-Jürgen Machulla and Bernd J Pichler
    Citation: Radiation Oncology 2011 6:165
  35. The Monte Carlo code GEANT4 was used to implement first steps towards a treatment planning program for fast-neutron therapy at the FRM II research reactor in Garching, Germany. Depth dose curves were calculate...

    Authors: Sylvia Garny, Werner Rühm, Maria Zankl, Franz M Wagner and Herwig G Paretzke
    Citation: Radiation Oncology 2011 6:163
  36. to evaluate activity and toxicity of a sequential treatment in advanced, non metastatic, mostly unresectable, head and neck squamous cell carcinoma.

    Authors: Stefano Pergolizzi, Anna Santacaterina, Barbara Adamo, Tindara Franchina, Nerina Denaro, Pina Ferraro, Giusy RR Ricciardi, Nicola Settineri and Vincenzo Adamo
    Citation: Radiation Oncology 2011 6:162
  37. Neoadjuvant chemoradiotherapy is the treatment of choice in advanced rectal cancer, even though there are many patients who will not benefit from it. There are still no effective methods for predicting which p...

    Authors: Chiara Molinari, Michela Ballardini, Nazario Teodorani, Massimo Giannini, Wainer Zoli, Ermanno Emiliani, Enrico Lucci, Alessandro Passardi, Paola Rosetti, Luca Saragoni, Massimo Guidoboni, Dino Amadori and Daniele Calistri
    Citation: Radiation Oncology 2011 6:161
  38. Brain metastases afflict approximately half of patients with metastatic melanoma (MM) and small cell lung cancer (SCLC) and represent the direct cause of death in 60 to 70% of those affected. Standard of care ...

    Authors: Kirtesh Patel, Nicole A Doudican, Peter B Schiff and Seth J Orlow
    Citation: Radiation Oncology 2011 6:160
  39. The quality of the interdisciplinary interface in oncological treatment between surgery, pathology and radiotherapy is mainly dependent on reliable anatomical three-dimensional (3D) allocation of specimen and ...

    Authors: Harald Essig, Majeed Rana, Andreas Meyer, André M Eckardt, Horst Kokemueller, Constantin von See, Daniel Lindhorst, Frank Tavassol, Martin Ruecker and Nils-Claudius Gellrich
    Citation: Radiation Oncology 2011 6:159
  40. To assess the accuracy of patient repositioning and clinical outcomes of frameless stereotactic radiosurgery (SRS) for brain metastases using a stereotactic mask fixation system.

    Authors: Giuseppe Minniti, Claudia Scaringi, Enrico Clarke, Maurizio Valeriani, Mattia Osti and Riccardo Maurizi Enrici
    Citation: Radiation Oncology 2011 6:158
  41. Stereotactic radiosurgery/radiotherapy procedures are known to deliver a very high dose per fraction, and thus, the corresponding peripheral dose could be a limiting factor for the long term surviving patients...

    Authors: Vassiliki Vlachopoulou, Christos Antypas, Harry Delis, Argyrios Tzouras, Nikolaos Salvaras, Dimitrios Kardamakis and George Panayiotakis
    Citation: Radiation Oncology 2011 6:157
  42. Radiation therapy is routinely prescribed for high-grade malignant gliomas. However, the efficacy of this therapeutic modality is often limited by the occurrence of radioresistance, reflected as a diminished s...

    Authors: Carlos A Fedrigo, Ivana Grivicich, Daniel P Schunemann, Ivan M Chemale, Daiane dos Santos, Thais Jacovas, Patryck S Boschetti, Geraldo P Jotz, Aroldo Braga Filho and Adriana B da Rocha
    Citation: Radiation Oncology 2011 6:156
  43. To report the clinical outcome after a Single Shot 3D-CRT PBI (SSPBI) in breast cancer patients after conservative surgery (ClinicalTrials.gov Identifier: NCT01316328).

    Authors: Paola Pinnarò, Stefano Arcangeli, Carolina Giordano, Giorgio Arcangeli, Fabrizio Ambesi Impiombato, Valentina Pinzi, Giuseppe Iaccarino, Antonella Soriani, Valeria Landoni and Lidia Strigari
    Citation: Radiation Oncology 2011 6:155
  44. In order to define new prognostic subgroups in patients with glioblastoma a miRNA screen (> 1000 miRNAs) from paraffin tissues followed by a bio-mathematical analysis was performed.

    Authors: Maximilian Niyazi, Franz Zehentmayr, Olivier M Niemöller, Sabina Eigenbrod, Hans Kretzschmar, Klaus Schulze-Osthoff, Jörg-Christian Tonn, Mike Atkinson, Simone Mörtl and Claus Belka
    Citation: Radiation Oncology 2011 6:153

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.3
    5-year Journal Impact Factor: 3.6
    Source Normalized Impact per Paper (SNIP): 1.197
    SCImago Journal Rank (SJR): 1.033

    Speed 2023
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 132

    Usage 2023
    Downloads: 1,958,690
    Altmetric mentions: 605